middle.news
EVE Health Accelerates Growth with $3M Nextract Biotech Acquisition
4:11am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
EVE Health Accelerates Growth with $3M Nextract Biotech Acquisition
4:11am on Monday 2nd of June, 2025 AEST
Key Points
Binding agreement to acquire 100% of Nextract for $3 million in equity
Nextract’s lead products target $5.3B erectile dysfunction and $10.9B dysmenorrhea markets
Capital raising of $1.5 million including $1 million placement and $0.5 million SPP
Shareholder meeting scheduled for 29 May 2025 to approve acquisition and 40:1 share consolidation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE